The city of Atlanta, Georgia, currently has 13 active clinical trials seeking participants for Depression research studies.
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention
Recruiting
This is a rater-blinded, randomized controlled trial. All patients will receive esketamine for treatment of Major Depression with Suicidal Ideation (MDSI). Subjects will be randomized (1:1) to receive CBT (computer-assisted) or TAU alone following esketamine.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
09/18/2023
Locations: Emory University, Atlanta, Georgia
Conditions: Depression and Suicide